China has approved a new obesity treatment from Pfizer Inc., heightening competition in a market poised to become even more ...

A Pfizer Inc. contract provision requiring employees to keep the subject and materials of arbitration proceedings ...

China's National Medical Products Administration has approved Pfizer Inc.’s PFE ecnoglutide injection for chronic weight management in adults with overweight or obesity, marking the first approval of ...

Pfizer Inc. has acquired exclusive rights to commercialize an obesity therapy in China, strengthening its push into the ...

(Bloomberg) -- A patient died after receiving Pfizer Inc.’s drug for hemophilia, marking another setback for the company in the treatment of blood disorders. The death occurred on Dec. 14 after the ...

Pfizer beat fourth-quarter sales estimates on strength from its older drugs as it races to fill gaps from its declining covid shot and pill franchises. Pfizer battled to acquire obesity startup ...